Compare CVS Health Corp (CVS) vs Western Union Co (WU) Price & Performance

CVS Health trades at $86.16, down 2.04% for the day, amid a bearish technical signal. The company reported strong earnings beats in recent quarters, with Q2 2026 EPS of $2.58 exceeding the $1.85 estimate. Revenue grew to $402.07 billion in 2025, though net income margin compressed to 1.18%. Analyst consensus is overwhelmingly positive, with 35 of 41 analysts rating the stock a Buy and a consensus price target of $111.20, implying significant upside. Recent news highlights Aetna's 2027 Medicare plan updates and a quarterly dividend declaration.

The outlook for CVS remains favorable based on fundamental strength and analyst optimism, but risks include reimbursement pressure, regulatory scrutiny, and a high debt load. The stock's current valuation metrics, such as a P/E of 23.17 and P/S of 0.27, appear reasonable relative to historical levels, supporting a constructive view for long-term investors despite near-term technical weakness.

Western Union (WU) trades at $6.12, showing minimal daily movement with a 0.16% gain. The stock demonstrates strong profitability with a 43.97% ROE and attractive valuation metrics including a 5.1 P/E ratio. Recent earnings have been mixed with two misses in the last three quarters, while technical indicators show a bullish overall signal despite bearish moving averages. The company's $200 million efficiency plan and Intermex acquisition represent significant strategic initiatives.

WU presents a value opportunity with deep discount valuation, but faces earnings volatility and competitive pressures. The 12.24% analyst buy rating reflects cautious optimism, with the $6.86 consensus target offering 12% upside. Key risks include integration challenges from acquisitions and margin pressure from digital transformation costs.